Home > Newsletters > Drug Industry Daily > FDA Finds Increased Minimization, Omission of Risk Info in Drug Promos
Drug Industry Daily
June 28, 2012 | Vol. 11 No. 127
FDA Finds Increased Minimization, Omission of Risk Info in Drug Promos
PHILADELPHIA — Drug and medical device companies are increasingly minimizing or omitting the risks associated with their products in advertising and promotional materials this year, an FDA official says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.